Clinical observation of HAIC-FOLFOX combined with camrelizumab in the treatment of unresectable hepatocellular carcinoma
|更新时间:2025-11-25
|
Clinical observation of HAIC-FOLFOX combined with camrelizumab in the treatment of unresectable hepatocellular carcinoma
“The latest research shows that the combination of HAIC-FOLFOX and Carilizumab is significantly effective in treating unresectable hepatocellular carcinoma, improving objective response rates, prolonging survival, reducing tumor marker levels, and improving immune function, but may increase the risk of immune related adverse events.”
ZHU Ping,LU Xiya,TIAN Yanfei.Clinical observation of HAIC-FOLFOX combined with camrelizumab in the treatment of unresectable hepatocellular carcinoma[J].ZHONGGUO YAOFANG,2025,36(22):2833-2837.
ZHU Ping,LU Xiya,TIAN Yanfei.Clinical observation of HAIC-FOLFOX combined with camrelizumab in the treatment of unresectable hepatocellular carcinoma[J].ZHONGGUO YAOFANG,2025,36(22):2833-2837. DOI: 10.6039/j.issn.1001-0408.2025.22.14.
Clinical observation of HAIC-FOLFOX combined with camrelizumab in the treatment of unresectable hepatocellular carcinoma